Business Description
MariMed Inc
NAICS : 325412
SIC : 2834
ISIN : US56782V1070
Total Employee Number:
923Description
MariMed Inc is a multi-state cannabis operator in the United States dedicated to improving lives every day through its high-quality products. The company develops, owns, and manages seed to sale state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It has created and continues to develop its own brands of cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other top cannabis products, in select domestic markets. Its operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which it operates.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 2.01 | |||||
Debt-to-EBITDA | 9.58 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.07 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | -32.4 | |||||
3-Year Book Growth Rate | -8.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.08 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.95 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.66 | |||||
9-Day RSI | 54.3 | |||||
14-Day RSI | 55.53 | |||||
3-1 Month Momentum % | -19.43 | |||||
6-1 Month Momentum % | -24.7 | |||||
12-1 Month Momentum % | -62.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.92 | |||||
Quick Ratio | 0.34 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 132.52 | |||||
Days Sales Outstanding | 19.41 | |||||
Days Payable | 45.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.1 | |||||
Shareholder Yield % | -0.93 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.63 | |||||
Operating Margin % | -0.82 | |||||
Net Margin % | -9.13 | |||||
EBITDA Margin % | 5.78 | |||||
FCF Margin % | 4.44 | |||||
OCF Margin % | 5.66 | |||||
ROE % | -28.56 | |||||
ROA % | -7.4 | |||||
ROIC % | -0.89 | |||||
3-Year ROIIC % | -60.59 | |||||
ROC (Joel Greenblatt) % | -2.15 | |||||
ROCE % | -1.55 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 8.57 | |||||
PS Ratio | 0.19 | |||||
PB Ratio | 0.71 | |||||
Price-to-Tangible-Book | 8 | |||||
Price-to-Free-Cash-Flow | 4.44 | |||||
Price-to-Operating-Cash-Flow | 3.2 | |||||
EV-to-EBIT | -50.76 | |||||
EV-to-EBITDA | 11.9 | |||||
EV-to-Forward-EBITDA | 7.62 | |||||
EV-to-Revenue | 0.69 | |||||
EV-to-Forward-Revenue | 0.69 | |||||
EV-to-FCF | 15.49 | |||||
Price-to-GF-Value | 0.57 | |||||
Price-to-Projected-FCF | 0.8 | |||||
Price-to-Median-PS-Value | 0.1 | |||||
Earnings Yield (Greenblatt) % | -1.97 | |||||
FCF Yield % | 22.54 | |||||
Forward Rate of Return (Yacktman) % | -30.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MRMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MariMed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 163.82 | ||
| EPS (TTM) ($) | -0.04 | ||
| Beta | 0.4508 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.81 | ||
| Volatility % | 60.69 | ||
| 14-Day RSI | 55.53 | ||
| 14-Day ATR ($) | 0.007844 | ||
| 20-Day SMA ($) | 0.076034 | ||
| 12-1 Month Momentum % | -62.79 | ||
| 52-Week Range ($) | 0.061 - 0.178 | ||
| Shares Outstanding (Mil) | 403.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MariMed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MariMed Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 61 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 59 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 08:00 | 0.06 (+2.97%) | ||
| Second quarter earnings results for 2026 | 2026-08-12 | 0.07 (+9.59%) | ||
| General meeting for 2025 | 2026-06-04 09:30 | 0.08 (-0.16%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 08:00 | 0.08 (+3.58%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.08 (-2.35%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-12 08:00 | 0.08 (-2.03%) | ||
| Annual report for 2025 | 2026-03-12 | 0.08 (-2.03%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-11 | 0.08 (-4.17%) |
Show
Entries
MariMed Inc Frequently Asked Questions
What is MariMed Inc(MRMD)'s stock price today?
The current price of MRMD is $0.08. The 52 week high of MRMD is $0.18 and 52 week low is $0.06.
When is next earnings date of MariMed Inc(MRMD)?
The next earnings date of MariMed Inc(MRMD) is 2026-11-05 Est..
Does MariMed Inc(MRMD) pay dividends? If so, how much?
MariMed Inc(MRMD) does not pay dividend.
Press Release
Articles on MariMed Inc
MariMed Inc (MRMD) Reports Q2 2026 Earnings: Revenue of $41.9 Million with a Net Loss of $3.6 Million
Aug 12, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers